Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 3 |
2022 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Data for modelling US projections of product approvals, patients treated, and product revenues for durable cell and gene therapies.
Data Brief. 2022 Feb 3;41:107891. doi: 10.1016/j.dib.2022.107891. eCollection 2022 Apr.
Data Brief. 2022.
PMID: 35198672
Free PMC article.
Durable cell and gene therapy potential patient and financial impact: US projections of product approvals, patients treated, and product revenues.
Young CM, Quinn C, Trusheim MR.
Young CM, et al.
Drug Discov Today. 2022 Jan;27(1):17-30. doi: 10.1016/j.drudis.2021.09.001. Epub 2021 Sep 17.
Drug Discov Today. 2022.
PMID: 34537333
Free article.
Review.
Item in Clipboard
Tracking the CAR-T Revolution: Analysis of Clinical Trials of CAR-T and TCR-T Therapies for the Treatment of Cancer (1997-2020).
Ivica NA, Young CM.
Ivica NA, et al. Among authors: young cm.
Healthcare (Basel). 2021 Aug 19;9(8):1062. doi: 10.3390/healthcare9081062.
Healthcare (Basel). 2021.
PMID: 34442199
Free PMC article.
Review.
Item in Clipboard
Cost-effectiveness of a hypothetical cell or gene therapy cure for sickle cell disease.
Salcedo J, Bulovic J, Young CM.
Salcedo J, et al. Among authors: young cm.
Sci Rep. 2021 May 25;11(1):10838. doi: 10.1038/s41598-021-90405-1.
Sci Rep. 2021.
PMID: 34035408
Free PMC article.
Item in Clipboard
Cite
Cite